EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction

Xiaoyan Gao iD, Xiaoting Liang iD, Baojuan Liu iD, Yimei Hong iD, Haiwei He iD, Ying Shen iD, Jiaqi Chen iD, Xinran Huang iD, Bei Hu iD, Weifeng Li iD, Xin Li iD, Yuelin Zhang iD

The FASEB Journal · 2023

DOI: 10.1096/fj.202301292r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Xiaoyan Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, South China University of Technology, Guangzhou, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Mesenchymal Stem Cells. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), the Foundation for Distinguished Scholars of Guangdong Provincial People's Hospital, the Natural Science Foundation for Distingusihed Scholars of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite promising results in myocardial infarction (MI), mesenchymal stem cell (MSC)‐based therapy is limited by cell senescence. N6‐methyladenosine (m6A) messenger RNA methylation has been reported to be closely associated with cell senescence. Nonetheless, its role in the regulation of MSC senescence remains unclear. We examined the role of ALKB homolog 5 (ALKBH5) in regulating MSC senescence and determined whether ALKBH5 downregulation could rejuvenate aged MSCs (AMSCs) to improve their therapeutic efficacy for MI. RNA methylation was determined by m6A dot blotting assay. MSC senescence was evaluated by senescence‐associated β‐galactosidase (SA‐β‐gal) staining. A mouse model of acute MI was established by ligation of the left anterior decedent coronary artery (LAD). Compared with young MSCs (YMSCs), m6A level was significantly reduced but ALKBH5 was greatly increased in AMSCs. Overexpression of ALKBH5 reduced m6A modification and accelerated YMSC senescence. Conversely, ALKBH5 knockdown increased m6A modifications and alleviated AMSC senescence. Mechanistically, ALKBH5 regulated the m6A modification and stability of CDKN1C mRNA, which further upregulated CDKN1C expression, leading to MSC senescence. CDKN1C overexpression ameliorated the inhibition of cellular senescence of ALKBH5 siRNA‐treated AMSCs. More importantly, compared with AMSCs, shALKBH5‐AMSCs transplantation provided a superior cardioprotective effect against MI in mice by improving MSC survival and angiogenesis. We determined that ALKBH5 accelerated MSC senescence through m6A modification‐dependent stabilization of the CDKN1C transcript, providing a potential target for MSC rejuvenation. ALKBH5 knockdown rejuvenated AMSCs and enhanced cardiac function when transplanted into the mouse heart following infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMesenchymal Stem CellsHumansAnimalsMiceAgedDown-RegulationAdenosineCellular SenescenceImmunologic FactorsRNA, MessengerAlkB Homolog 5, RNA Demethylase

Stichwörter der Autor:innen

ALKBH5mesenchymal stem cellmyocardial infarctionrejuvenationsenescence

Substanzen

AdenosineImmunologic FactorsRNA, MessengerALKBH5 protein, humanAlkB Homolog 5, RNA Demethylase

Autor:innen und Institutionen

  • School of Medicine, South China University of Technology, Guangzhou, China.
  • Department of Emergency Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Xiaoyan Gao, Xiaoting Liang, Baojuan Liu, Yimei Hong, Haiwei He, Ying Shen, Jiaqi Chen, Xinran Huang, Bei Hu, Weifeng Li, Xin Li, Yuelin Zhang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • the Foundation for Distinguished Scholars of Guangdong Provincial People's Hospital
  • the Natural Science Foundation for Distingusihed Scholars of Guangdong Province
  • the Science and Technology Planning Project of Guangzhou
  • National Natural Science Foundation of China

Zitieren

APA

Gao, X., Liang, X., Liu, B., Hong, Y., He, H., Shen, Y., Chen, J., Huang, X., Hu, B., Li, W., Li, X., & Zhang, Y. (2023). Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction. The FASEB Journal. https://doi.org/10.1096/fj.202301292r

Vancouver

Gao X, Liang X, Liu B, Hong Y, He H, Shen Y, et al. Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction. The FASEB Journal. 2023. doi:10.1096/fj.202301292r

BibTeX
@article{Gao2023,
  author = {Gao, Xiaoyan and Liang, Xiaoting and Liu, Baojuan and Hong, Yimei and He, Haiwei and Shen, Ying and Chen, Jiaqi and Huang, Xinran and Hu, Bei and Li, Weifeng and Li, Xin and Zhang, Yuelin},
  title = {Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202301292r}
}
Kostenlos starten →